Antimicrobial effect of benzbromarone combined with colistin against multidrug-resistant bacteria
IntroductionDrug-resistant respiratory pathogens in COPD patients pose a major therapeutic challenge. Colistin is a last-resort treatment for drug-resistant infections. But emerging resistance and hepatorenal toxicity limit its use, which highlights the need for combination strategies to improve its...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2025-09-01
|
| Col·lecció: | Frontiers in Medicine |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1665514/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|